darunavir
- Product NDC
- 76282-738
- Requested package NDC
- 76282-738-30
- 11-digit product format
- 762820738
- Labeler code
- 76282
- Product ID
- 76282-738_d4f6fed4-1a95-4d9a-8395-13818dedccd3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- darunavir 800 mg
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- EXELAN PHARMACEUTICALS INC.
- Application
- ANDA206288
- Marketing category
- ANDA
- Marketing start
- 2024-01-19
- Substance
- DARUNAVIR HYDRATE
- Active strength
- 800 mg/1
- Pharmacologic classes
- Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206288-001 | DARUNAVIR | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | |
| A206288-002 | DARUNAVIR | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A206288-001 | AB |
| A206288-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A206288-001 | DARUNAVIR | 600MG | TABLET / ORAL | AB | 2023-11-28 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | A206288-002 | DARUNAVIR | 800MG | TABLET / ORAL | AB | 2023-11-28 | 1c564ffb4f44… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-12-20 04:57 UTC | 2023-12 | A206288-001 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A206288-002 | AB | 1 | ea1830bbd6c7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A206288-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A206288-002 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- darunavir
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DARUNAVIR HYDRATE | 800 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| KPC4NRB25L | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| ed977166-7ac0-4a8c-a10c-4b19a69403c0 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 81157882-d7f5-4b49-9a52-b2a0c7e54020 | Product name | 2 | 20260107 |
| 12fd8c59-0b3a-2882-9cdb-92782ec03e2f | Product name | 6 | 20251113 |
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| a56d673d-fa42-4b0e-b5ce-e65a5eab34b7 | Product name | 1 | 20180911 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| d723478e-ad4a-ec23-6bd7-cfe33e1e3840 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76282-738-30 | darunavir | 30 in 1 BOTTLE | TABLET | 30 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76282-738-30 | EA - Each | 76282-738 | 72aadd52-5a10-4ee8-a63a-62d8e66cf86c | 1 | 2024-02-14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Darunavir | DARUNAVIR | American Health Packaging | 632293b0-d220-444e-8a5b-2ee8c225b66d | 2026-09-15 | Warnings, Adverse reactions | 206288 ANDA206288 |
| Darunavir 600 and 800 mg | DARUNAVIR | Bryant Ranch Prepack | bf99d8b8-c4e0-4cb4-924e-8cdcfd8d1aa1 | 2025-06-05 | Warnings, Adverse reactions | 206288 ANDA206288 |
| darunavir | DARUNAVIR 600 MG | EXELAN PHARMACEUTICALS INC. | ed977166-7ac0-4a8c-a10c-4b19a69403c0 | 2024-01-19 | Warnings, Adverse reactions | 206288 ANDA206288 76282-738-30 76282-738 76282073830 |
| Darunavir 600 and 800 mg | DARUNAVIR | Cipla USA Inc. | 5624cc30-d484-458e-b234-9bb745a118ca | 2024-01-18 | Warnings, Adverse reactions | 206288 ANDA206288 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 670026 | darunavir 600 MG Oral Tablet | PSN | ed977166-7ac0-4a8c-a10c-4b19a69403c0 | 1 |
| 1359269 | darunavir 800 MG Oral Tablet | PSN | ed977166-7ac0-4a8c-a10c-4b19a69403c0 | 1 |
| 670026 | darunavir 600 MG Oral Tablet | SCD | ed977166-7ac0-4a8c-a10c-4b19a69403c0 | 1 |
| 1359269 | darunavir 800 MG Oral Tablet | SCD | ed977166-7ac0-4a8c-a10c-4b19a69403c0 | 1 |
| 670026 | darunavir (as darunavir ethanolate) 600 MG Oral Tablet | SY | ed977166-7ac0-4a8c-a10c-4b19a69403c0 | 1 |
| 1359269 | darunavir (as darunavir ethanolate) 800 MG Oral Tablet | SY | ed977166-7ac0-4a8c-a10c-4b19a69403c0 | 1 |
| 670026 | darunavir (as darunavir hydrate) 600 MG Oral Tablet | SY | ed977166-7ac0-4a8c-a10c-4b19a69403c0 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 76282-738-30 | 76282073830 | 30 TABLET in 1 BOTTLE (76282-738-30) | 30 tablet | 2024-01-19 | No | No | Current |